Effect of CD4 + T cell count and antiretroviral treatment on two serological HIV incidence assays

AIDS Research and Human Retroviruses

Volumn 28, Issue 1, 2012, Pages 95-99

  Hladik, Wolfgang ^a,b   Olara, Dennis ^a   Mermin, Jonathan ^a   Moore, David ^a,c   Were, Willy ^a   Alexander, Lorraine ^a   Downing, Robert ^a  

^a CDC Uganda   (Uganda)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ANTIVIRAL THERAPY; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROLOGY; TREATMENT OUTCOME;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; FEMALE; HIV ANTIBODIES; HIV SEROPOSITIVITY; HIV-1; HUMANS; INCIDENCE; MALE; VIRAL LOAD;

EID: 79959954779     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2010.0347     Document Type: Article

References (21)

1. Parekh BS, Kennedy MS, Dobbs T, et al.: Quantitative detection of increasing HIV type 1 antibodies after seroconversion: A simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002;18(4):295-307. (Pubitemid 34253148)
2. Parekh BS and McDougal JS: Application of laboratory methods for estimation of HIV-1 incidence. Indian J Med Res 2005;121(4):510-518. (Pubitemid 40691380)
3. Parekh BS, Hanson DL, Hargrove J, et al.: Determination of mean recency period for estimation of HIV Type 1 incidence with the BED-capture EIA in persons infected with diverse subtypes. AIDS Res Hum Retroviruses. Epub October 18, 2010.
4. Guy R, Gold J, Calleja JM, et al.: Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: A systematic review. Lancet Infect Dis 2009;9(12):747-759.
5. Karita E, Price M, Hunter E, et al.: Investigating the utility of the HIV-1 BED capture enzyme immunoassay using crosssectional and longitudinal seroconverter specimens from Africa. AIDS 2007;21(4):403-408.
6. Martro E, Suligoi B, Gonzalez V, et al.: Comparison of the avidity index method and the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion, two methods using a single serum sample for identification of recent HIV infections. J Clin Microbiol 2005; 43(12):6197-6199. (Pubitemid 43100691)
7. Kaleebu P, Whitworth J, Hamilton L, et al.: Molecular epidemiology of HIV type 1 in a rural community in southwest Uganda. AIDS Res Hum Retroviruses 2000;16(5):393-401. (Pubitemid 30193807)
8. Masciotra S, Dobbs T, Candal D, Hanson D, Delaney K, and Rudolph D: Antibody avidity-based assay for identifying recent HIV-1 infections based on Genetic System 1/2 Plus O EIA. Conference on Retroviruses and Oppportunistic Infections (CROI), 2010, San Francisco.
9. Hall HI, Song R, Rhodes P, et al.: Estimation of HIV incidence in the United States. JAMA 2008;300(5):520-529.
10. Mermin J, Musinguzi J, Opio A, et al.: Risk factors for recent HIV infection in Uganda. JAMA 2008;300(5):540-549.
11. Laeyendecker O, Oliver AE, Astemborski J, Owen SM, Kirk G, Mehta S, et al.: Improved precision of cross-sectional HIV incidence testing using a multi-assay algorithm that includes BED and avidity assay with modified cut-offs. Conference on Retroviruses and Oppportunistic Infections (CROI), 2010, San Francisco.
12. Fiamma A, Lissouba P, Amy OE, et al.: Can HIV incidence testing be used for evaluating HIV intervention programs? A reanalysis of the Orange Farm male circumcision trial (ANRS-1265). BMC Infect Dis 2010;10:137.
13. Laeyendecker O, Church JD, Oliver AE , et al.: Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay. PLoS One 2010;5(10):e13259.
14. Hargrove JW, Humphrey JH, Mutasa K, et al.: Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS 2008;22(4):511-518. (Pubitemid 351317293)
15. Hayashida T, Gatanaga H, Tanuma J, and Oka S: Effects of low HIV type 1 load and antiretroviral treatment on IgGcapture BED-enzyme immunoassay. AIDS Res Hum Retroviruses 2008;24(3):595-598.
16. Marinda ET, Hargrove J, Preiser W, et al.: Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy. J Acquir Immune Defic Syndr 2010;53(4):596-599.
17. Laeyendecker O, Rothman RE, Henson C, et al.: The effect of viral suppression on cross-sectional incidence testing in the Johns Hopkins hospital emergency department. J Acquir Immune Defic Syndr 2008;48(2):211-215.
18. Li H, Ketema F, Sill AM, et al.: A simple and inexpensive particle agglutination test to distinguish recent from established HIV-1 infection. Int J Infect Dis 2007;11(5):459-465. (Pubitemid 47243812)
19. Loschen S, Batzing-Feigenbaum J, Poggensee G, et al.: Comparison of the human immunodeficiency virus (HIV) type 1-specific immunoglobulin G capture enzyme-linked immunosorbent assay and the avidity index method for identification of recent HIV infections. J Clin Microbiol 2008;46(1):341-345.
20. Schupbach J, Gebhardt MD, Tomasik Z, et al.: Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation. PLoS Med 2007;4(12):e343.
21. Guidelines for using HIV testing technologies in surveillance. 2001. Geneva, UNAIDS/WHO Working Group on Global HIV/AIDS/STI Surveillance